催产素与米索前列醇用于足月引产的临床观察

Clinical Observation of Misoprotol and Oxytocin Administering to Term Induction

目的探讨催产素与米索前列醇用于足月妊娠引产及对引产结局的影响。方法于2008年1月至2009年12月对280例妊娠足月引产的孕妇分别应用催产素静滴引产与阴道放置米索前列醇25μg引产,观察相应疗效。结果使用催产素后,产妇临产发动时间及总产程增长、剖宫产率下降,有统计学意义。结论催产素用于足月妊娠引产比米索前列醇用于足月妊娠引产安全。

Objective To discuss the autcome of administering oxytocin and misoprotol to term induction.Methods From January 2008 to December 2009,208 cases of pregnant women were given intravenous oxytocin to induce labor and were given 25 mg misoprostol in vagina to observe the outcome.Results After using oxytocin,launch time labor and total process of these pregant women were extended,the rate of cesaren section was decreased,there was statistical significance. Conclusion It is safer administering oxytocin than misoprostol in term prognancy induction.